Pilot RCT of a Chinese Medicine Diabetes Education Programme
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorThe Hong Kong Polytechnic University
About this trial
The goal of this clinical trial is to learn if a Chinese medicine diabetes education programme is feasible and acceptable, and to explore its preliminary effects on self-management, for adults with type 2 diabetes in Hong Kong. The main questions it aims to answer are:
1. Is the Chinese medicine diabetes education programme feasible to deliver in a community setting (recruitment, retention and adherence)? 2. Is the programme acceptable to participants? 3. Does the programme show early signals of improving diabetes management self-efficacy and related outcomes?
Researchers will compare the Chinese medicine education programme to usual care to see if the programme is feasible, acceptable and shows preliminary benefits.
Participants will:
1. Be randomly assigned to either a 4-week Chinese medicine diabetes education programme (four group sessions, total 4-6 hours) or usual care 2. Complete assessments at baseline, after the programme, and at 2-month follow-up. 3. Attend a focus group interview at the end of the study (selected participants)
Outcome assessors will be blinded to group allocation.
Eligibility criteria
Qualifiers
Adults aged 18 years or above
Diagnosed with type 2 diabetes mellitus
Able to understand and communicate in Cantonese, and able to read Chinese
Willing and able to provide written informed consent
Disqualifiers
Severe cognitive impairment that would prevent meaningful participation in group education
Acute or unstable medical conditions, or serious chronic illnesses currently under active treatment (e.g., ongoing cancer treatment), that may preclude safe participation in group activities
Currently participating in another structured diabetes education research programme
Pregnancy
Trial design
Treatments tested in this trial
- Chinese Medicine Diabetes Education Programme
Treatment groups
40 Participants
are divided into 2 treatment groupsLocations
Sponsors and collaborators
Source ClinicalTrials.gov